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The human eye proteome project
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The human eye proteome is the latest addition to the HUPOHuman Proteome Project (HPP).
Semba et al. (The Human Eye Proteome Project: Perspectives on an emerging proteome.
Proteomics 2013, 13, 2500–2511) establish a provisional baseline for the proteomes of the many
anatomical compartments of the eye, based on literature review. As part of the Biology and
Disease-driven HPP, they and their colleagues will generate fresh data and meet the stringent
guidelines for protein identification and characterization as established by the HPP.
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In this issue, Semba et al. [1] lay the foundation for a new
component of the HUPO Biology and Disease-driven Hu-
manProteomeProject (B/D-HPP), theHumanEye Proteome
Project. The goal is to gain insights into the pathophysiology
of eye diseases and contribute to new preventive and thera-
peuticmodalities. Figure 1 shows our update of the B/D-HPP
diagram published in January 2013 [2] to include now the eye
proteome.
The B/D-HPP comprises (i) the pre-existingHUPO organ-
and biofluid-based proteome projects developed over the past
decade—the plasma, liver, brain, kidney/urine, stem cells,
cardiovascular, and model organisms proteome projects and
the human antibody, glycoproteomics, and protein standards
initiatives, and (ii) new teams on diabetes, cancers, infectious
diseases, epigenetics/chromatin, mitochondria, and now the
eye. An additional teamon autoimmune disorders is being or-
ganized. Details on theHPP andB/D-HPP executive commit-
tees and investigator teams are available at www.thehpp.org.
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The B/D-HPP and the overall HPP have the ambitious
goal of fundamentally transforming biological research by
enabling the reliable detection and quantification of every hu-
man protein by the broad life science research community.
As illustrated by the SRM study of ovarian cancer associated
proteins in plasma and urine by Huttenhain et al. [3], tar-
geted MS is now well established with software programs
for assay development, robust data analysis tools, spectral li-
brary repositories, and SRM Atlas resources, as well as new
data-independent acquisition MS methods [2].
Semba et al. [1] have compiled from literature reports us-
ing MS a total of 4842 nonredundant protein identifications
across the many compartments of the eye, including the
cornea (3708), tear film (1698), choroid (897), retina (672),
vitreous humor (545), aqueous humor (465), and lens (273).
Studies are not available for the ciliary body, sclera, iris, and
optic nerve body. Many of these results are from studies of
pathological conditions affecting the eye. The authors com-
bined results fromUniProt (Universal Protein Resource) and
IPI (International Protein Index) with a clustering tool for se-
quence homology >90% to remove duplicates and isoform
redundancy. MS Data Miner was used to generate subpro-
teome lists for eye compartments. Unfortunately, most of
these studies lack quality measures or confidence parameters
for the diverse datasets tallied up in this review.
The authors’ Supporting Information Table 2 shows the
various criteria used by each of the included studies for
protein and peptide identifications. It appears that many
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Figure 1. Current set of 16-investigator teams for the Biology and
Disease-driven Human Proteome Project (B/D-HPP), with addition
of the Eye Proteome Project.
studies accepted identifications based on matching only one
peptide. Raw spectra are available for only one of the 24
studies. Standardized reprocessing of data through Trans-
Proteomic-Pipeline to create a Human-Eye PeptideAtlas is
not feasible without the raw data. As the Eye ProteomeProject
proceeds, it will be highly desirable to create such an Eye Pep-
tideAtlas, using the same stringent 1% false discovery rate
(FDR) at the protein level (corresponding to about 0.2% FDR
at the peptide level) that yielded 1929 canonical proteins for
the 2010 build of the Human-Plasma PeptideAtlas [4] and
12 629 proteins for the 2012 build of the overall Human Pep-
tideAtlas (G. S. Omenn, paper submitted) [5]. Thus, the 4842
grand total for eye protein identifications should be consid-
ered provisional, perhaps similar to the exhaustive list of 9504
proteins for plasma in the original plasma proteome paper [6]
or, more likely, the “sequence-unique” list in the 2010 Plasma
PeptideAtlas [7].
The average FDR for the datasets included in the current
reviewmust be much higher than 1% FDR, as acknowledged
by the authors. In fact, the history of protein counts in theHu-
man Plasma Proteome Project is instructive: the first publica-
tion presented a core dataset of 3020 protein identifications,
based on two or more matching peptides and the author’s as-
sertion of “high confidence” [6]. Subsequently, a much more
stringent analysis, including a Bonferroni-type adjustment
for multiple comparisons, yielded 889 proteins [8]. As part of
the B/D-HPP, the Eye Proteome investigators will have assis-
tance from the PeptideAtlas teamof theHPP for standardized
analyses.
As fresh data are generated for each component of the eye,
this team will be able to cross-analyze the Eye PeptideAtlas
with thePlasmaPeptideAtlas to ascertainwhether proteotypic
peptides have already beendetected in plasma that could serve
as accessible biomarkers for the corresponding proteins in-
side the eye, especially for studies of the prevention, progres-
sion, or treatment of eye diseases. As a demonstration of the
approach, they have compared the provisional eye proteome
with the 2010 build of the Human-Plasma PeptideAtlas and
found 1317 proteins common to eye and plasma, 3525 only in
the eye, and 611 only in the plasma. As Semba et al. [1] note,
future studies will take account of PTMs, alternative splice
isoforms, polymorphic mutations (SNPs, single nucleotide
polymorphisms), and protein complexes, as will the overall
HPP.
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